According to global head for product supply Achim Noack: "Our goal is to apply our world-class production and supply chain expertise to our rapidly growing global seed production and processing infrastructure."
CEO Sandra Petersen also told the company's annual press conference: "We believe the products that are in our pipeline of new seed, small molecules and biological crop solutions hold significant promise in the market, and expect the peak sales potential for our products being launched from 2011 to 2016 to be at least €4 billion."
The company also intends to spend €5 billion in research and development between 2011 and 2016. Last month it concluded a €500 million takeover of US biocontrols specialist AgraQuest.
Petersen will take a new role as group worldwide chairman of Johnson & Johnson in December.